
Fixing Insurance Gaps:
New NPLB Research Finds ACA Plans Hike Patient Rx Out-of-Pocket Costs Despite Enhanced Taxpayer Subsidies
Key Research Findings:
Health Plan Growth: The number of people with healthcare coverage through the ACA marketplace health exchange plans grew by 79% since 2021.
Cost-Shifting to Patients: Since 2021, Affordable Care Act exchange plans have shifted 36% more prescription drug costs onto enrollees, driving average annual out-of-pocket spending up by ~$150 (from $412.64 to $560.75).
$2,000 Rx Cap = High Taxpayer Value, Low Health Plan Risk: Only 5% of ACA enrollees spend over $2,000 annually on prescriptions.
The Bottom Line:
Congress should set a $2,000 Rx out-of-pocket cap in health exchange plans. This would protect patients, preserve plan design flexibility, and deliver greater value to taxpayers, all while having a minimal impact on premiums.
Read the full report.
Read the press release.
We’re building support across the biotech ecosystem
BECOME A FIRST RESPONDER & THOUGHT PARTNER
Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.